Video Library

Join us live in Austin, TX or virtually on May 11-15 for 4 days of education, networking and fun!
Gary Ulaner, MD, PhD, FACNM
A recent AONN+ annual conference session discussed an FDA-approved PET imaging agent, which is used as an adjunct to biopsy for the detection of estrogen receptor (ER)-positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.
Frank dela Rama, RN, MS, AOCNS,Sara Campbell, BS, BSN, OCN,Jim G.
In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results.
AONN+ invites you to join us for the Virtual 12th Annual Navigation & Survivorship Conference on November 17-21, 2021. In this virtual experience, we are bringing together AONN+ Leadership, Local Navigator Network leaders, and more than 1000 oncology navigators and cancer professionals for 4 days of education and empowerment.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Patients with metastatic disease rely on their oncology navigator to help meet their treatment needs, psychosocial needs, family needs, and individual needs.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Cassie Osborne, RN, MSN, OCN, ONN-CG explains the misconceptions patients can have when they receive a metastatic disease diagnosis.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Healthcare needs a greater focus on metastatic survivors and establishing treatment goals that the patient wants to proceed with.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Cassie Osborne, RN, MSN, OCN, ONN-CG shares how oncology navigators serve as the voice of their patients who are living with metastatic disease.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Patients are living longer and thriving with metastatic disease, but there are still a lot of complications and concerns that need to be addressed for this patient population.
Cassie Osborne, RN, MSN, OCN, ONN-CG
Patients who are living with chronic and metastatic disease face a unique set of challenges in their care coordination.